Bisindolylmaleimide III is a protein kinase C ( PKC ) inhibitor with IC 50 values of 0.26, 5.7, and 6 μM against PKCα , PKCδ , and PKCμ , respectively. Bisindolylmaleimide III also exhibits inhibitory activity against other off-targets, with IC 50 values of 0.17, 1, and 2 μM against SLK , adenosine kinase ( AK ), and CDK2 , respectively; its K i for NQO2 is 16.5 μM. Bisindolylmaleimide III selectively binds to activated Rsk1 following EGF stimulation, and serves as a tool for detecting the activation status of intracellular Rsk1 and PKCα , as well as for functional analysis of SLK . Bisindolylmaleimide III can be used in studies of signal transduction and colorectal cancer .
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Adenosine Kinase | Products > Signaling Pathways > CDK | Products > Signaling Pathways > Quinone Reductase | Products > Signaling Pathways > PKC | Products > Signaling Pathways > SLK
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。